Conditional survival (CS) for patients with metastatic renal cell carcinoma (mRCC) treated with vascular endothelial growth factor (VEGF)-targeted therapy (TT): Results from the international mRCC database consortium.
Toni K. Choueiri
No relevant relationships to disclose
Wanling Xie
No relevant relationships to disclose
Lauren Christine Harshman
No relevant relationships to disclose
Georg A. Bjarnason
No relevant relationships to disclose
Jennifer J. Knox
No relevant relationships to disclose
Mary J. MacKenzie
No relevant relationships to disclose
Lori Wood
No relevant relationships to disclose
Ulka N. Vaishampayan
No relevant relationships to disclose
Min-Han Tan
No relevant relationships to disclose
Sun Young Rha
No relevant relationships to disclose
Frede Donskov
No relevant relationships to disclose
Neeraj Agarwal
No relevant relationships to disclose
Christian K. Kollmannsberger
No relevant relationships to disclose
Scott A. North
No relevant relationships to disclose
Brian I. Rini
No relevant relationships to disclose
Daniel Yick Chin Heng
No relevant relationships to disclose